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Other names: CADASIL; CASIL 
Location: 19p13.12 




The Notch3 gene is encoded by 33 exons spanning 
41.35 kb that are located on chromosome 19p13.12. 
Transcription 
8.089 kb mRNA, the coding sequence is from 77 bp-
7042 bp. 
Protein 
Note: 2321 amino acids with a predicted molecular 
mass of 243.66 kD. 
Single-pass type I membrane protein. Contain 1 signal 
peptide, 36 extracellular EGF repeats, 1 single 
transmembrane domain, and 2 PEST domains. 
Synthesized in the endoplasmic reticulum as an 
inactive form, which is cleaved by a furin-like 
convertase in the trans-Golgi complex before it reach s 
the plasma membrane to yield an active, ligand-
accessible form. Cleavage results in a transmembrane 
Notch subunit (NTM) and an extracellular Notch 
subunit (ECN). 
Description 
Notch3 is a cell surface receptor for membrane-bound 
ligands including Jagged1, Jagged2, Delta-like1, Delta-
like3 and Delta-like4. It is activated by ligand-receptor 
interaction, which triggers two successive proteolytic 
cleavages that release the active intracellular domain of 
Notch (NICD). The NICD translocates to the nucleus, 
where it interacts with CSL (CBF1/RBP-J kappa, 
Suppressor of Hairless, LAG-1). Binding of NICD to 
CSL displaces corepressor complexes and recruits 
coactivators, leading to transcription from promoters 
containing CSL-binding elements. The Notch3 target 
genes participate in wide spectrum of biological 
processes such as differentiation, proliferation and 
apoptosis. 
Expression 
Expressed in certain types of fetal and adult tissue . 
Localisation 
Mainly located at cell membrane. Following proteolytic 
events upon ligand binding, its intracellular domain is 
translocated into the nuclei. 
Function 
Notch3 is a membrane receptor that mediates cell-cell 




Mutation in NOTCH3 is associated with cerebral 
autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy (CADASIL). 
CADASIL is an adult-onset disorder characterized by 
recurrent ischemic strokes, dementia, and premature 
death. It affects predominantly the small cerebral 
arteries, leads to progressive degeneration of 
vasculature smooth-muscle cells. 
Disease-associated mutations are distributed througout 
the epidermal growth factor-like repeats (EGFRs) that 
compose the extracellular domain of the Notch3 
receptor and result in a loss or a gain of a cysteine 
residue in one of these EGFRs. Mutation hotspots were 
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located at the two exons encoding the first five EGFRs. 
The findings suggested that aberrant dimerization of 
NOTCH3, due to abnormal disulfide bridging with 
NOTCH3 molecule or another protein, may be 
involved in the pathogenesis of CADASIL. 
Somatic 
Somatic sequence mutations, gene translocation and 
amplification of chromosomal locus involved Notch3 
gene were identified in T-cell lymphoma, non-small-
cell lung cancer and ovarian cancer, respectively. 
Implicated in 




A breakpoint was localized to the cosmid R31546. The
breakpoint was found about 50 kilobases (kb) upstream 
of the Notch3 and within the 3' untranslated region of a 
putative gene, Hunk1, on 19p. Translocation of 
chromosome 19p was also found in several other 
chromosomes, including chromosomes 12q, 14q, 17q, 
4q, and 6q. Overexpression of Notch3 full-length 
mRNA is associated with a 19p translocation. 
Oncogenesis 
The translocation is associated with Notch3 over-
expression. Transgenic mouse study by constitutive 
expression of intracellular domain of Notch3 in lung 
epithelium using surfactant protein C. 
promoter/enhancer resulted in inhibited differentiation 
of epithelial lung cell, altered lung morphology, and 
perinatal lethality in the transgenic mice. 
Ovarian cancer-serous type 
Cytogenetics 
Chromosome 19p13.12 amplification harboring the 
Notch3 gene is frequently identified in ovarian caner. 
Oncogenesis 
In vitro study demonstrated that cell lines with Notch3 
over-expression are more sensitive to the anti-
proliferative effect of Notch3 signaling pathway 
inhibitors including gamma-secretase inhibitor and 
Notch3-specific siRNA. 
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